QuVa Pharma, Inc. recalls PHENYLephrine 1 mg/10 mL (100 mcg/mL) in 0.9% Sodium Chloride, 10 mL syringe, packaged in 24 syringes per case, Rx only…
- Recall date
- March 30, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1066-2016
- FDA classification
- Class I
- Brand / firm
- QuVa Pharma, Inc.
- Sold / distributed
- CA
Why it was recalled
Labeling: Label Error on Declared Strength. Product has correct label on the syringe and the case but some units are incorrectly labeled as .4 mg/10 mL (40 mcg/ml) on the light protective overwrap of each syringe.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
PHENYLephrine 1 mg/10 mL (100 mcg/mL) in 0.9% Sodium Chloride, 10 mL syringe, packaged in 24 syringes per case, Rx only, Healix Infusion Therapy Inc, 1075 W Park One Drive, Suite 200, Sugar Land Texas 77478, Product Code: 75901-1205-35.
Get recall alerts
Free email alert whenever QuVa Pharma, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: QuVa Pharma, Inc.